Dapagliflozin, metformin (Synglutra, Dapagliflozin Metformin Cipla)
Dapagliflozin, metformin
Cipla Medpro (Pty) Ltd
Registration
- Applicant
- Cipla Medpro (Pty) Ltd
- Registrations
- 7
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Synglutra 5/500 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 5/500 | 53064953/21.2/0649 | Registered | Not determined | None |
| Synglutra 10/500 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 10/500 | 53065053/21.2/0650 | Registered | Not determined | None |
| Synglutra 5/1 000 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 5/1 000 | 53065153/21.2/0651 | Registered | Not determined | None |
| Synglutra 10/1 000 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 10/1 000 | 53065253/21.2/0652 | Registered | Not determined | None |
| Dapagliflozin metformin cipla 5/500 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 5/500 | 530653.64953/21.2/0653.649 | Registered | Not determined | None |
| Dapagliflozin metformin cipla 5/1 000 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 5/1 000 | 530655.65153/21.2/0655.651 | Registered | Not determined | None |
| Dapagliflozin metformin cipla 10/1 000 ECAH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 10/1 000 | 530656.65253/21.2/0656.652 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Dapagliflozin
Consolidated Schedules 06 July 2026, line 5942
S3: Metformin
Consolidated Schedules 06 July 2026, line 3938
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.